Med X Tech Summit Asia

2018-06-23

MEDTEX Summit Asia:Foresee the Next Wave of Healthcare Revolution
Plenary Session: Future Trends for Global Healthcare Industry and Investment

Parallel Session Parallel Session I: New Evolution for Smart Healthcare
Parallel Session II: New Vision for Cell Therapy

	Parallel Session III: New Strategy for Pharmaceutical R&D Registration Iformation_Plenary Session (Future Trends & Investment) + Parallel Session I (Smart Healthcare)
 Plenary Session (Future Trends & Investment) + Parallel Session II (Cell Therapy)
Plenary Session (Future Trends & Investment) + Parallel Session III (Pharma R&D)Fee/Session

NOTE:1.Your event registration QR code, in print or an e-copy, is required for the entry. 2.Headsets for simultaneous interpretation will be provided for free. Visitors can request for a headset with a photo ID which will be returned after the headset being collected.

MEDTEX Registration
 MEDTEX Foresee the Next Wave of Healthcare Revolution
Plenary Session:Globally known venture capitalists from Polaris, Partners Healthcare, J&J and PITANGO (Israel), including Amir Nashat the Forbes Top 100 VCs, will project their views on where and what in healthcare that VCs holding $20bn would find fascinating.


Parallel SessionI:New Evolution for Smart Healthcare •CEOs at Microsoft, Philips and Nvidia will join with the pioneer in the use of medical AI, Dr. Shortliffe, sharing regulatory trends and their global initiatives in medical AI, smart senor, IoT & cloud computing.


Parallel Session II: New Vision for Cell Therapy Mari Dezawa (Japan) the discoverer of Muse cells, Massimo Dominici, Shin Kawamata and Yutaka Kawakami the expert of hematopoietic stem cell therapy, together with Novartis and Pluristem (Israel) the front-runners of CAR-T and placental stem cell therapy, will talk through how they go about gene therapy and cellular therapy.


Parallel Session III: New Strategy for Pharmaceutical R&D, Aaron Ciechanover (Israel), the winner of Nobel Prize in Chemistry will host the session focusing on strategic drug development alongside leading experts at Novartis, IBM and Agios Pharmaceuticals.
Reistration Information:1.Plenary Session (Future Trends & Investment) + Parallel Session I (Smart Healthcare)
Plenary Session (Future Trends & Investment) + Parallel Session II (Cell Therapy)
 3.Plenary Session (Future Trends & Investment) + Parallel Session III (Pharma R&D)
Fee/SessionNote:1.Your event registration QR code, in print or an e-copy, is required for the entry.2.Headsets for simultaneous interpretation will be provided for free. Visitors can request for a headset with a photo ID which will be returned after the headset being collected.

MEDTEX Registration